Zobrazeno 1 - 10 of 251 pro vyhledávání: '"Carsten, Otto"'
2
Moderne Antidiabetika nach Metformin
Autor: Carsten Otto
Publikováno v: CME. 18:51-58
Die Moglichkeiten in der Therapie des Typ-2-Diabetes haben sich in den letzten Jahren erfreulicherweise deutlich verbessert. Wahrend Metformin das Mittel der ersten Wahl bleibt und demnach bei fast allen Typ-2-Diabetikern eingesetzt wird, hat sich vo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fb7eee28f186ecc18f82a6bbda419386
https://doi.org/10.1007/s11298-021-2000-8
Zobrazit plný text záznamu
3
Wann ist der Diabetiker in der Hausarztpraxis richtig versorgt?
Autor: Carsten Otto
Publikováno v: MMW - Fortschritte der Medizin. 160:41-44
Typ-2-Diabetiker werden uberwiegend in der Hausarztpraxis versorgt. Klappt das wirklich immer gut? Die wichtigsten Aufgaben — von der Fruhdiagnostik uber die Festlegung der Therapieziele bis hin zu Kontrolluntersuchungen — fasst der nachfolgende
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b78968179206e76122181280c93d367c
https://doi.org/10.1007/s15006-018-0432-1
Zobrazit plný text záznamu
5
Analyzing Program Termination and Complexity Automatically with AProVE
Autor: Peter Schneider-Kamp, Stephanie Swiderski, Carsten Otto, Florian Frohn, Marc Brockschmidt, Jera Hensel, Jürgen Giesl, Martin Plücker, Thomas Ströder, Carsten Fuhs, René Thiemann, Fabian Emmes, Cornelius Aschermann
Publikováno v: Giesl, J, Aschermann, C, Brockschmidt, M, Emmes, F, Frohn, F, Fuhs, C, Hensel, J, Otto, C, Plücker, M, Schneider-Kamp, P, Ströder, T, Swiderski, S & Thiemann, R 2017, ' Analyzing Program Termination and Complexity Automatically with AProVE ', Journal of Automated Reasoning, vol. 58, no. 1, pp. 3-31 . https://doi.org/10.1007/s10817-016-9388-y
In this system description, we present the tool AProVE for automatic termination and complexity proofs of Java, C, Haskell, Prolog, and rewrite systems. In addition to classical term rewrite systems (TRSs), AProVE also supports rewrite systems contai
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20ed30e232c853f8e57d105104d9844a
https://findresearcher.sdu.dk:8443/ws/files/141379108/Analyzing_Program_Termination_and_Complexity_Automatically_with_AProVE.pdf
Zobrazit plný text záznamu
6
Long-term LDL apheresis does not stably improve hemorheology in hypercholesterolemic patients with coronary artery disease
Autor: Thomas Pusl, Uli C. Broedl, Klaus G. Parhofer, Carsten Otto
Publikováno v: Clinical Hemorheology and Microcirculation. 41:137-142
Hemorheological abnormalities are independent cardiovascular risk indicators and adversely affect the outcome of cardiovascular disease. Single LDL apheresis treatment was shown to improve blood and plasma viscosity, red cell aggregation and deformab
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bfc24a182d1a2ae78ad81c838549850
https://doi.org/10.3233/ch-2009-1166
Zobrazit plný text záznamu
7
Short-term therapy with atorvastatin or fenofibrate does not affect plasma ghrelin, resistin or adiponectin levels in type 2 diabetic patients with mixed hyperlipoproteinaemia
Autor: Andreas Pfeiffer, K. G. Parhofer, R. J. A. Frost, Jochen Spranger, Bärbel Otto, Carsten Otto, M. Vogeser
Publikováno v: Acta Diabetologica. 44:65-68
Lipid-lowering therapy is associated with reduced cardiovascular risk. The aim of the present study was to investigate whether lipid-lowering therapy might be associated with changes in the concentrations of metabolically important hormone concentrat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22c1388ea42b9fee36dfefde30d59e98
https://doi.org/10.1007/s00592-007-0244-8
Zobrazit plný text záznamu
8
Effect of Atorvastatin (10 mg/day) on Glucose Metabolism in Patients With the Metabolic Syndrome
Autor: Sebastian Huptas, Carsten Otto, Hans-Christian Geiss, Klaus G. Parhofer
Publikováno v: The American Journal of Cardiology. 98:66-69
Large interventional studies have shown that statins may reduce the incidence of type 2 diabetes mellitus. However, it is uncertain whether short-term statin therapy can affect insulin sensitivity in patients with the metabolic syndrome. We evaluated
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efffee41e24ca7f05839492cd83c7dfc
https://doi.org/10.1016/j.amjcard.2006.01.055
Zobrazit plný text záznamu
9
u-Opiate receptor agonists - a new pharmacological approach to prevent motion sickness?
Autor: Rudolf L. Riepl, Joachim Klose, Sibylle Klosterhalfen, Carsten Otto, Bärbel Otto, Paul Enck
Publikováno v: British Journal of Clinical Pharmacology. 61:27-30
Aims Stress hormones might be involved in motion sickness. The influence of loperamide on kinetosis-induced nausea and stress hormone release was investigated in a placebo-controlled, cross-over study. Methods Standardized rotation around the vertica
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6b5b9d1dcbc5f8fbcd2399db232c174
https://doi.org/10.1111/j.1365-2125.2005.02505.x
Zobrazit plný text záznamu
10
In vivo metabolism of LDL subfractions in patients with heterozygous FH on statin therapy
Autor: H.C. Geiss, Carsten Otto, S. Bremer, P. H. R. Barrett, Klaus G. Parhofer
Publikováno v: Journal of Lipid Research, Vol 45, Iss 8, Pp 1459-1467 (2004)
LDL can be subfractionated into buoyant (1.020-1.029 g/ml(-1)), intermediate (1.030-1.040 g/ml(-1)), and dense (1.041-1.066 g/ml(-1)) LDLs. We studied the rebound of these LDL-subfractions after LDL apheresis in seven patients with heterozygous famil
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87a1f48782ec17ffa83321c6f57f3928
http://www.sciencedirect.com/science/article/pii/S0022227520313079
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje